Amanda Johnson (Johnson) Winters MD
Psychosomatic Medicine, Women Focused
Consultation-Liaison Psychiatrist, Great River Health Systems
Join to View Full Profile
1225 S Gear AveSte 251West Burlington, IA 52655
Phone+1 319-768-3700
Fax+1 319-768-3712
Dr. Winters is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Amanda (Johnson) Winters, MD, specializes in psychiatry, with subspecialties in psychosomatic medicine and women's health in West Burlington, IA. She earned her medical degree from the University of Alabama School of Medicine in 2006, and furthered her education with a psychiatry residency at the University of Virginia Medical Center and a Consultation-Liaison Psychiatry fellowship at Virginia Commonwealth University Health System. Dr. Winters currently works as an Inpatient Psychiatrist at Great River Health Systems and has had a stint as an instructor at Harvard Medical School. She has an extensive list of publications from her days in bench research, primarily focusing on acute myeloid leukemia, which has been cited by many other publications.
Education & Training
Virginia Commonwealth University Health SystemFellowship, Consultation-Liaison Psychiatry, 2010 - 2011
University of Virginia Medical CenterResidency, Psychiatry, 2006 - 2010
University of Alabama School of MedicineClass of 2006
Certifications & Licensure
IA State Medical License 2013 - 2026
MA State Medical License 2011 - 2014
VA State Medical License 2006 - 2012
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Psychosomatic Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification P2 Sentinel, Cerner Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification FirstNet (Image Results), Cerner Corporation, 2015-2017
Publications & Presentations
PubMed
- 160 citationsNicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem CellsCourtney L. Jones, Brett M. Stevens, Daniel A. Pollyea, Rachel Culp-Hill, Julie A. Reisz
Cell Stem Cell. 2020-11-05 - 54 citationsSingle‐center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemiaAmanda Winters, Kelly W. Maloney, Amy L. Treece, Lia Gore, Anna K. Franklin
Pediatric Blood & Cancer. 2020-07-31 - 243 citationsMonocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.Shanshan Pei, Daniel A. Pollyea, Annika Gustafson, Brett M. Stevens, Mohammad Minhajuddin
Cancer Discovery. 2020-01-23
Abstracts/Posters
- Venetoclax and Azacitidine for Older Newly Diagnosed Patients with Acute Myeloid Leukemia: A Single-Institution Pilot Study Using Measurable Residual Disease to Guide ...Amanda Winters, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based TherapyAmanda Winters, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- COVID-19 Changes Lives, Jobs of Health Care WorkersMarch 10th, 2021
Committees
- member, Pharmacy & Therapeutics 2015 - Present
- member, Credentials Committee 2015 - 2016
Professional Memberships
- Member
- Academy of Psychosomatic MedicineMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
